Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Autoantibodies to RNA helicase A: a new serologic marker of early lupus.

Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Abstract Text:

    yoshioki yamasakiYoshioki Yamasaki,sonali narainSonali Narain,hideo yoshidaHideo Yoshida,liza hernandezLiza Hernandez,tolga barkerTolga Barker,paulette c hahnPaulette C Hahn,eric s sobelEric S Sobel,mark s segalMark S Segal,hanno b richardsHanno B Richards,edward k l chanEdward K L Chan,westley h reevesWestley H Reeves,minoru satohMinoru Satoh,

    OBJECTIVE: To investigate the clinical and immunologic significance of autoantibodies to RNA helicase A (RHA) in patients with systemic rheumatic diseases. METHODS: The study group comprised 1,119 individuals enrolled in the University of Florida Center for Autoimmune Diseases registry from 2000 to 2005. Diagnoses were based on standard criteria. Autoantibodies were analyzed by immunoprecipitation and Western blot assays. RESULTS: Anti-RHA was observed in 17 (6.2%) of 276 patients with systemic lupus erythematosus (SLE), 2 patients with antiphospholipid antibodies, and 3 other patients, but anti-RHA was not observed in any patient with polymyositis/dermatomyositis, systemic sclerosis, rheumatoid arthritis, or Sjögren's syndrome. Anti-RHA was present in only 2.9% of African American patients, compared with 6.0% of white patients and 12-25% of patients of other races; this was in striking contrast to the frequency of anti-Sm in African American patients (27.2%). Among patients with SLE, anti-RHA was common in young patients (26% of those whose initial visit was at an age younger than 20 years versus 3-4% of those who were initially seen at ages 20-49 years) and at an early stage of disease (23% of those whose first clinic visit was within 1 year of disease onset versus 2-8% of those whose first visit was at least 1 year after disease onset). In 9 of 11 patients, levels of anti-RHA decreased to <10% of the initial value within 9-37 months, while levels of coexisting anti-Ro or anti-Su remained the same. New specificities developed in 2 patients (anti-nuclear RNP and anti-Sm, and anti-ribosomal P, respectively). These data suggest that the level of anti-RHA diminishes over time, and that anti-RHA is regulated via a mechanism different from that for other lupus-related autoantibodies. CONCLUSION: Anti-RHA is a new serologic marker for SLE. It is produced mainly in young non-African Americans at an early stage of their disease. Anti-RHA has a unique tendency to diminish over time. The production of anti-RHA may depend on a process restricted to early SLE, or it may be highly sensitive to treatment.

    Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Publishing Authors By Initials

    y yamasakiY Yamasaki,s narainS Narain,h yoshidaH Yoshida,l hernandezL Hernandez,t barkerT Barker,pc hahnPC Hahn,es sobelES Sobel,ms segalMS Segal,hb richardsHB Richards,ek chanEK Chan,wh reevesWH Reeves,m satohM Satoh,

    For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Arthritis and rheumatism

    VOLUME: 56

    Page Numbers: 596-604

    Journal Abbreviation: Arthritis Rheum.

    ISSN: 0004-3591

    DAY: 3

    MONTH: Feb

    YEAR: 2007

    Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370605

    Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Keywords Mesh Terms:

    KEYWORDS: Time Factors

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Information

    Substance Name: DHX9 protein, human

    Registry Number: EC 3.6.1.-

    Grant and Affiliation Information for Autoantibodies to RNA helicase A: a new serologic marker of early lupus.

    AFFILIATION: University of Florida, Gainesville, FL 32610, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: M01-RR-00082

    ACRONYM: RR

    MEDLINETA: Arthritis Rheum

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Autoantibodies to RNA helicase A: a new serologic marker of early lupus Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News